Clinical Trial Update: The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia. [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes ongoing Phase 1/Phase 2 evaluation of allogeneic mesenchymal stem cell therapy for hair regrowth in androgenetic alopecia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• Allogeneic mesenchymal stem cell therapy

Snippet

Sponsor: National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | Conditions: Androgenetic Alopecia, Androgenetic Alopecia (AGA) | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION